✦ LIBER ✦

Combination vs conventional therapy for Crohn's disease

Book ID: 120844012
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 121 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816270-00018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness Analysis of Azathiopr

Cost-Effectiveness Analysis of Azathioprine vs. Infliximab vs. Combination Therapy for Crohn's Disease

✍ Andrew R. Reinink; Martin Gregory; Steven Kymes; Themistocles Dassopoulos 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Infliximab, Azathioprine, or Combination

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

✍ Colombel, Jean Frédéric; Sandborn, William J.; Reinisch, Walter; Mantzaris, Gera 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 337 KB

Initial combination therapy in early Cro

Initial combination therapy in early Crohn's disease

✍ William J Sandborn 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 56 KB

Ciprofloxacin and metronidazole: Combina

Ciprofloxacin and metronidazole: Combination antibiotic therapy for ileocolonic Crohn's disease

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Infliximab vs. Adalimumab for Crohn's di

Infliximab vs. Adalimumab for Crohn's disease

✍ P. Mulani; J. Chao 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB

Postoperative therapy for Crohn's diseas

Postoperative therapy for Crohn's disease

✍ Eric Blum; Jeffry A. Katz 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Prevention of the postoperative recurrence of Crohn's disease (CD) remains a challenging clinical problem. The majority of patients with CD will need surgery for treatment of the disease, most of these patients will develop recurrent symptoms within 5 years postoperatively, and many patients will ne